Advertisement
Articles
Advertisement

Spinal-Cord Injury Therapy OK'd By FDA Could Lead To Cures

Thu, 08/02/2012 - 5:38am

video platformvideo managementvideo solutionsvideo player

The Food and Drug Administration has approved a phase 1 clinical trial to evaluate the safety of transplanting human Schwann cells to treat patients with paralysis. It is the first such trial in the world.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading